Maryland biotech subsidiary gets $50M in funding to further cell therapy manufacturing
December 02, 2022 at 14:49 PM EST
The new subsidiary, Morgenesis, will be located at the Maryland Center for Cell Therapy Manufacturing, a collaboration between the company and Johns Hopkins Medicine. The company hopes make it more affordable for startups and universities to create cell therapies for clinical trials.